Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Appropriation Targets $100,000 To Find Safe CBD Level In Supplements

Related Content

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Dec 19 2017

'Innovation' Meeting Shows FDA-Industry Gap On NDI Guidance Details Remains

May 20 2019

Congress Should Open CBD Door, Close VMS Market Holes – Sharfstein, Cohen

Jun 14 2019

House Appropriators' Report Tracks With FDA Concern About CBD Supplements

Jun 05 2019

Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient

May 24 2019

Additional Topics

US States United States Dietary Supplements Legislation FDA Advertising, Marketing & Sales Compliance Manufacturing Ingredients Enforcement Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window